Biller Jonathan sold VRTX

December 3, 2025 · Form 4 insider transaction

Biller Jonathan sold 347 shares of Vertex Pharmaceuticals Incorporated at $449.00 per share, a transaction worth $155.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
347
Price
$449.00
Total value
$155.8K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 3, 2025
Filing dateDecember 5, 2025
Shares owned after15,306
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025.

View the original Form 4 on SEC EDGAR